Abvc Biopharma Inc (ABVC) Return on Equity ROE from the first quarter 2026 to first quarter 2024 and annually, average high and low, overall ranking from Mar 31 2026 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abvc Biopharma Inc   (NASDAQ: ABVC)

Abvc Biopharma Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Abvc Biopharma Inc in the first quarter 2026?
Abvc Biopharma Inc recorded a cumulative net loss of $-7 million during 12 months ending in the first quarter 2026, resulting in a negative return on equity (ROE) of -56.28%.

Within the Major Pharmaceutical Preparations industry 152 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from 0 to 2775.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Equity Change 61.24 % 709.83 % 841.08 % 550.65 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -7 -5 -5 -5 -8
Return On Equity (TTM) -56.28 % -48.59 % -55.79 % -102.36 % -244.59 %
ABVC's Total Ranking # 2775 # 0 # 2781 # 2538 # 3004
Equity (TTM) in Millions 13 13 14 9 8
Seq. Equity Change -3.53 % -8.25 % 52.72 % 19.27 % 384.55 %
Seq. Net Income Change - - - - -

Back to ABVC Management Effectiveness >> ABVC's 5 Years Annual ROE >> Compare ABVC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 153
Sector # 369
Overall # 2775

Return On Equity Statistics
High Average Low
-41.55 %
-206.98 %
-538.84 %
(Dec 31 2025)   (Dec 31 2021)





ABVC Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Equity in Millions 13 3 9 -6 -2
Y / Y Equity Change 310.91 % -63.52 % - - -
Net Income in Millions -8 -16 -12 -4 -4
Y / Y Net Income Change - - - - -
Return On Equity -63 % -504.07 % -135.69 % - -

Back to ABVC Management Effectiveness >> ABVC's 5 Years Annual ROE >> Compare ABVC ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ABVC's' Return on Equity at Yahoo Finance
ABVC's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ABVC's Competitors
Subscribers only: Roe for Abvc Biopharma Inc 's Suppliers
Subscribers only: Return On Equity for ABVC's Customers




Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector ROE

Date modified: 2026-09-12T06:12:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.